Cashu | News | EXEL

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Exelixis News

AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?

Feature Image for interests on Basic Materials, Benzinga Pro, Communication Services, Consumer Cyclical from benzinga.com

Futures Rise Ahead Of Data Deluge, S&P Set For 7th Straight Record High

Feature Image for interests on Consumer Cyclical, Consumer Defensive, Consumer Discretionary, CryptoCurrency from zerohedge.com

Assessing Exelixis: Insights From 12 Financial Analysts

Stocks making the biggest moves midday: Tesla, Novo Nordisk, Hims & Hers, Northern Trust, Fiserv and more

Feature Image for interests on Basic Materials, Breaking News: Economy, Breaking News: Markets, Consumer Cyclical from cnbc.com

about 1 month ago

Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday

Feature Image for interests on Big Gainers, Consumer Cyclical, Consumer Defensive, Financial Services from benzinga.com

about 1 month ago

Exelixis Targets $5 Billion In Sales With Promising Data In Key Colorectal Cancer Drug Trial, Stock Soars

Feature Image for interests on Analyst Color, Briefs, Expert Ideas, Healthcare from benzinga.com

about 1 month ago

What 9 Analyst Ratings Have To Say About Exelixis

about 1 month ago

12 Health Care Stocks Moving In Monday's Pre-Market Session

about 1 month ago

Analyst Expectations For Exelixis's Future

about 2 months ago

Price Over Earnings Overview: Exelixis

Latest Cashu News

Exelixis Struggles Amid Market Optimism Following Disappointing Sales of Cancer Treatment

Exelixis Struggles Amid Market Optimism and Declining Cancer Drug Sales

Exelixis: Navigating Mixed Analyst Opinions Amid Biotechnology Industry Challenges

Stocks

Health Care

exel

Exelixis

NASDAQ: EXEL

+1.05 (+2.90%)

37.27

USD

At close at Aug 01, 20:36 UTC